Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Divi's Laboratories (DIVI IN)
Watchlist
125
Analysis
Health Care
•
India
Divi's Laboratories Ltd. manufactures pharmaceutical products which include generic drugs and their intermediates. The Company also undertakes contract research activities for other pharmaceutical companies.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Varun Beverages
•
06 Dec 2024 07:01
Nifty Next50 Index Rebalance Preview: Big Capping Flows in December; Methodology Change Coming?
The introduction of new F&O contracts will result in an estimated 21.9% turnover and a one-way trade of INR 75bn (US$881m) for the Nifty Next50...
Brian Freitas
Follow
975 Views
Share
bullish
•
Persistent Systems
•
03 Dec 2024 06:30
NIFTY200 Momentum30 Index Rebalance Preview: 65% One-Way Turnover and US$1.6bn Trade
We forecast 19 changes for the index in December. One-way turnover is estimated at 65.2% resulting in a one-way trade of INR 71bn (US$837m). The...
Brian Freitas
Follow
835 Views
Share
bullish
•
Eternal
•
21 Nov 2024 05:50
NIFTY200 Momentum30 Index Rebalance Preview: More Changes with New F&O Stocks
We forecast 17 changes a side for the index in Dec. Some of the changes have changed following 45 new F&O inclusions. The forecast adds have...
Brian Freitas
Follow
908 Views
Share
bullish
•
HDFC Bank
•
24 Oct 2024 06:30
India: Potential Free Float Changes & Passive Flows in November
Changes to shareholding patterns could lead to changes in float for some stocks in local/global indices. Passive trackers will need to trade over 4...
Brian Freitas
Follow
846 Views
Share
bullish
•
Voltas
•
23 Oct 2024 06:50
NIFTY200 Momentum30 Index Rebalance Preview: 56% Turnover, Big Trade & Strong Momentum
There could be 16 constituent changes in December. one-way turnover is estimated at 55.6% and that will result in a one-way trade of INR 62bn...
Brian Freitas
Follow
939 Views
Share
First
Previous
11
12
13
14
15
16
17
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x